Stone X Group Inc. Harmony Biosciences Holdings, Inc. Transaction History
Stone X Group Inc.
- $1.58 Billion
- Q1 2025
A detailed history of Stone X Group Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Stone X Group Inc. holds 15,573 shares of HRMY stock, worth $544,120. This represents 0.03% of its overall portfolio holdings.
Number of Shares
15,573
Previous 20,779
25.05%
Holding current value
$544,120
Previous $715,000
27.69%
% of portfolio
0.03%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding HRMY
# of Institutions
287Shares Held
45MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$231 Million91.68% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$204 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.7MShares$164 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$55.2 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.29MShares$45 Million0.03% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.07B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...